Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abide, America, appointed, ASC, attempt, Bell, borrow, breach, characterize, codified, collateral, collaterized, Condemnation, description, discontinued, disinterested, Doshi, enrichment, expedited, faith, favor, fiduciary, fill, Folsom, fraud, ground, idle, interference, investigation, Irrevocable, Jitendra, lead, led, lieu, maintenance, memorandum, misappropriation, misuse, modified, monetary, monetory, notification, notified, opened, panel, partly, plaintiff, pronouncement, proxy, quickly, recover, released, remanded, reply, resignation, resigned, resume, serve, shareholder, Similarly, stand, Standby, stipulate, stipulated, stipulation, tender, thousand, Topic, unfair, unfulfilled, unjust, unused, vacancy
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 2.01 Exhibit 2.01
- 3.01 Exhibit 3.01
- 3.02 Exhibit 3.02
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25
- 10.26 Exhibit 10.26
- 10.27 Exhibit 10.27
- 10.28 Exhibit 10.28
- 10.29 Exhibit 10.29
- 10.30 Exhibit 10.30
- 10.31 Exhibit 10.31
- 10.32 Exhibit 10.32
- 31.1 Exhibit 31.1
- 31.2 Exhibit 31.2
- 32.1 Exhibit 32.1
Related press release
CPD similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Quarterly Report on Form 10-Q of Caraco Pharmaceutical Laboratories, Ltd. (“Caraco”) for the period ended September 30, 2009 (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their respective knowledge and belief, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Caraco.
| /s/ Jitendra N. Doshi | ||
| Jitendra N. Doshi | ||
| Chief Executive Officer | ||
| /s/ Mukul Rathi | ||
| Mukul Rathi | ||
| interim Chief Financial Officer | ||
November 9, 2009